China Veterinary Medicine Market Size & Outlook, 2026-2033
Global Market
Related Markets
China veterinary medicine market highlights
- The China veterinary medicine market generated a revenue of USD 2,631.5 million in 2025 and is expected to reach USD 5,807.2 million by 2033.
- The China market is expected to grow at a CAGR of 10.5% from 2026 to 2033.
- In terms of segment, pharmaceuticals was the largest revenue generating product in 2025.
- Medicated Feed Additives is the most lucrative product segment registering the fastest growth during the forecast period.
Veterinary medicine market data book summary
| Market revenue in 2025 | USD 2,631.5 million |
| Market revenue in 2033 | USD 5,807.2 million |
| Growth rate | 10.5% (CAGR from 2026 to 2033) |
| Largest segment | Pharmaceuticals |
| Fastest growing segment | Medicated Feed Additives |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biologics, Pharmaceuticals, Medicated Feed Additives |
| Key market players worldwide | Zoetis Inc Class A, Boehringer Ingelheim, Merck & Co Inc, Elanco Animal Health Inc, Dechra Pharmaceuticals, Ceva Santé Animale, Phibro Animal Health Corp Class A, Virbac SA, Bimeda Ireland, Biogenesis Bago |
Other key industry trends
- In terms of revenue, China accounted for 5.1% of the global veterinary medicine market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China veterinary medicine market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 4,239.4 million by 2033.
China's veterinary medicine market is anticipated to grow over the forecast period. The factors contributing to the market growth include growing awareness among owners and increasing animal adoption.
The surge in number of pet families in the country is accompanied by the growing demand for veterinary drugs. The need for veterinary drugs has increased significantly in recent years due to the pet industry's explosive growth, making it essential for stronger R&D efforts.
In May 2022, the criteria for clinical authorization of veterinary biological products were prioritized and streamlined. The minimum requirement for the number of animals used in clinical trials to develop veterinary biological products was decreased from at least 200 animals to at least 50 animals.
No credit card required*
Publish Date: Apr 06, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Veterinary Medicine Market Scope
Veterinary Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Zoetis Inc Class A | View profile | 14,100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | www.zoetis.com |
| Virbac SA | View profile | 5,400 | 2065m LID, 1 ere avenue, Carros, France, 06516 | www.virbac.com |
| Merck & Co Inc | View profile | 72,000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | www.merck.com |
| Elanco Animal Health Inc | View profile | 9,800 | 2500 Innovation Way, Greenfield, IN, United States, 46140 | www.elanco.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | www.boehringer-ingelheim.com/ |
| Dechra Pharmaceuticals | View profile | 501-1000 | Northwich, Cheshire, United Kingdom, Europe | www.dechra.com |
| Ceva Santé Animale | View profile | 5001-10000 | Libourne, Aquitaine, France, Europe | www.ceva.us |
| Phibro Animal Health Corp Class A | View profile | 1,920 | 300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712 | www.pahc.com |
| Biogenesis Bago | View profile | 501-1000 | Garín, Buenos Aires, Argentina, South America | www.biogenesisbago.com/en/ |
| Bimeda Ireland | View profile | 1001-5000 | Tallaght, Dublin, Ireland, Europe | www.bimeda.ie/ |
China Veterinary Medicine Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Veterinary Medicine Market Outlook will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 62.29% in 2025.
Horizon Databook has segmented the China veterinary medicine market based on biologics, pharmaceuticals, medicated feed additives covering the revenue growth of each sub-segment from 2021 to 2033.
China's veterinary medicine market is anticipated to grow over the forecast period. The factors contributing to the market growth include growing awareness among owners and increasing animal adoption.
The surge in number of pet families in the country is accompanied by the growing demand for veterinary drugs. The need for veterinary drugs has increased significantly in recent years due to the pet industry's explosive growth, making it essential for stronger R&D efforts.
In May 2022, the criteria for clinical authorization of veterinary biological products were prioritized and streamlined. The minimum requirement for the number of animals used in clinical trials to develop veterinary biological products was decreased from at least 200 animals to at least 50 animals.
- China Veterinary Medicine Market Product Outlook (Revenue, USD Million , 2021-2033)
- Biologics
- Pharmaceuticals
- Medicated Feed Additives
- China Veterinary Medicine Market Animal Type Outlook (Revenue, USD Million , 2021-2033)
- Companion Animals
- Production Animals
- China Veterinary Medicine Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
- Oral
- Other Routes
- Injectable
- Topical
- China Veterinary Medicine Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
- E-commerce
- Offline Retail Stores
- Others
- Veterinary Hospitals & Clinics
Reasons to subscribe to Veterinary Medicine Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Veterinary Medicine Market Outlook databook
- Our clientele includes a mix of Veterinary Medicine Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China Veterinary Medicine Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Veterinary Medicine Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
China Veterinary Medicine Market, 2021-2033 (US$M)
China veterinary medicine market statistics, by product, 2021-2033 (US$M)
